exhibition The congress is accompanied by an exhibition; an important factor in contributing to the congress’s educational function, by allowing participants to gain access to high-quality information and advice.

ECNP would therefore like to invite companies and organisations involved in clinical and pre-clinical research, diagnosis and treatment of disorders of the brain to present their services, products and/or literature at the exhibition, which will be held simultaneously with the congress from Sunday 8 September to Tuesday 10 September 2019.

Coffee and lunch will be served in the exhibition area, to facilitate maximum contact between exhibitors and participants.

For prices and more information please read the exhibition guidelines.  

List of exhibitors

Below you will find all companies and organisations involved in the exhibition of the 32nd ECNP Congress.

In alphabetical order:

 Brazilian Association of Psychiatry (ABP)  15
 ECHO (European Consortium for Observational Studies on Mental Health Products)  13 
 EUFAMI  21 
 European Brain Council (EBC) 22 
 European Psychiatric Association (EPA) 16
 Femtonics Ltd. 17
 FENS 14 
 Frontiers  25
 GAMIAN-Europe 20 
 H. Lundbeck A/S   2 & 4
 JAMA Network 23 
 Janssen Cilag LTD
 Janssen EMEA
 Janssen Pharmaceutica NV 6
 MEDICE Arzneimittel Pütter GmbH & Co. KG 10 
 Neuroscience-based Nomenclature (NbN) 18
 RECORDATI S.p.A & Gedeon Richter Plc
 Sage Therapeutics, Inc. 8
 Saladax Biomedical 9
 SEI Healthcare LLC 11 
 Shire Denmark A/S, part of the Takeda group 12 
 Sunovion Pharmaceuticals Europe
 The International College of Neuropsychopharmacology (CINP)  26
 Transmedica A/S 27
 Wisepress Medical Bookshop 24 

Exhibition floor plan

FINAL Exhibition floor plan
It is no longer possible to apply. The deadline for application for exhibition space was 15 December 2018.

The organisers made initial stand space assignments for applications received before 15 December 2018, taking into account the restrictions of the congress venue and, as much as possible, the applicant’s preferences.
After the initial stand space assignment was been finalised, the remaining space (if available) was allocated to later applications.